Media OutReach
From PolyU Research to Geneva Global Debut: GOOD Vision oka³y! ™ Redefines Precision in Freeform Orthokeratology
Beyond Traditional Toric Lenses: The Future of Freeform Orthokeratology
With myopia expected to affect 50% of the world’s population by 2050, demand for effective management is high. While Ortho-K is a highly effective strategy, traditional symmetric and spherical/ toric designs often underestimate corneal shape complexity, causing lens decentration and poor visual outcomes.
The oka³y!™ freeform technology, incorporating the company’s proprietary FAST-360 and CORe Technology, surpasses traditional lens design. AI-based FAST-360 reconstructs missing corneal data for faster scans, while CORe ensures precise alignment with the visual axis, leading to 3.1 times greater stability.
Precision Myopia Correction and Control for High Astigmatism and Asymmetric Corneas
For optometrists and clinic owners, oka³y!™’s key benefit is improving workflow by automating complex mathematics, cutting chair time by 64%. This boosts myopia management capacity without extra staff or lengthy training. “As a registered optometrist in Hong Kong and a researcher in one of the world’s leading optometric institutes, I witnessed a growing gap between the number of patients seeking Ortho-K and the limited range of conventional products available to treat them,” says Dr. Kin Ho Chan, Ken, the lead inventor of oka³y!™. “By focusing on the ‘3A’: AI-guided, Astigmatism, and Asymmetry, and working alongside The Hong Kong Polytechnic University (Poly U), we have developed a design that not only delivers superior vision but also enhances safety by reducing corneal staining. We are turning a frustrating, manual trial-and-error process into a predictable one-click adjustment.”
From Niche Specialty to Global Enterprise: Scaling the Future of Eye Care
As myopia rates reach epidemic levels, GOOD Vision partners with PolyU, harnessing its research strengths and support from its startup ecosystem PolyVentures, to redefine primary eye care by transforming a niche specialty into a scalable global enterprise. By replacing manual OK lens design with oka³y!™, the company has created a technology bridging clinical complexity and scalability. This transition enables practitioners to manage myopia, high astigmatism, and asymmetrical cases precisely, removing barriers to modern refractive error management.
“By embedding and automating the complex mathematics of lens design, we provide clinicians with the tools to treat ‘difficult’ patients who were previously considered unsuitable for Ortho-K,” added Professor Chea-su Kee, Founder of GOOD Vision. “This is about elevating the global standard of care and ensuring that precision myopia management is accessible to the next generation on a global scale.”
Experience the Future of Myopia Control
GOOD Vision invites investors, distributors, and practitioners to a live demonstration of the oka³y!™ at the International Exhibition of Inventions Geneva:
- Location: PolyU Delegation Booth, Hall 2, Palexpo, CP 112, Route François-Peyrot 30, 1218 Le Grand-Saconnex, Geneva, Switzerland
- Dates: 11–15 March 2026
Hashtag: #GOODVision
The issuer is solely responsible for the content of this announcement.
About GOOD Vision Technologies Co., Limited
GOOD Vision, a Hong Kong-based startup nurtured by PolyU, is dedicated to advancing the field of corneal reshaping technologies. With a focus on innovation, efficiency, and affordability, the company develops innovative solutions to empower eye practitioners and enhance the quality of eye care worldwide.
For additional details about GOOD Vision and their innovative offerings, please visit https://www.linkedin.com/company/goodvisiontech
As awareness around women’s health continues to grow, menopause remains a life stage that is frequently underserved by mainstream health solutions. JR Life Sciences is responding to this gap with a science-backed, plant-derived formulation that offers a natural alternative to conventional hormone-based therapies, one that is both accessible and aligned with the preferences of today’s health-conscious consumer.
Menopause Relief is a once-daily capsule containing three plant-based phytoestrogens, each selected for their clinically studied benefits in managing menopause symptoms and supporting long-term health. The formulation is free from synthetic hormones and is suitable for both vegetarian and vegan diets, making it broadly accessible across diverse consumer lifestyles.
Key active ingredients include:
- Lifenol Hops Extract (8-PN phytoestrogen): Shown to lessen hot flushes, night sweats, sleep disturbances, restlessness and irritability while helping to maintain total-body bone-mineral density.
- Flax Lignan (SDG phytoestrogen): Provides gentle hormonal support that helps balance oestrogen levels during the transition.
- Soy Isoflavone (genistein and daidzein): Supports bone strength, reduces hot flashes and steadies mild mood swings.
The launch of Menopause Relief reflects a broader strategic priority for JR Life Sciences: to expand its women’s health portfolio in response to growing consumer demand for natural health solutions. In Singapore, where an ageing population is driving increased interest in preventive health and targeted supplementation, the company sees a significant opportunity to better serve women navigating the menopause transition.
Holistic Way currently distributes a comprehensive range of nutraceuticals across key health categories, including:
- Musculoskeletal Health: Products categorised under joint supplements to address knee pain and mobility concerns in ageing demographics.
- Immunity & General Health: Daily essentials ranging from Vitamin C tablets and multivitamin supplements to vitamins for the immune system.
- Specialised Care: Targeted formulations including eye health supplements, probiotics supplements, and heart health supplements.
- Beauty & Wellness: Functional supplements such as collagen shots, hair growth supplements, and anti-ageing supplements.
As JR Life Sciences prepares for 2027, its focus remains on addressing unmet market needs and evolving consumer expectations. Guided by a commitment to science-backed innovation and quality, the company continues to invest in building a future-ready product pipeline that supports long-term well-being and reinforces trust among consumers in Singapore and beyond.
Menopause Relief is now available through Holistic Way’s retail and digital channels. For more information, visit https://holisticway.com.sg/.
Hashtag: #HolisticWay
The issuer is solely responsible for the content of this announcement.
About Holistic Way
Holistic Way is a leading Singapore-based health supplement brand under JR Life Sciences, committed to supporting holistic wellbeing through science-led nutrition. The brand offers a comprehensive range of supplements formulated to support key health areas, including immunity, hormonal balance, joint health, digestive wellness, and healthy ageing. Guided by evidence-based research and stringent quality standards, Holistic Way focuses on delivering effective, reliable solutions that address both everyday wellness needs and specific life-stage concerns. Through its emphasis on scientific integrity and product excellence, Holistic Way empowers individuals to take proactive control of their health and well-being.
Emerging economies are becoming the EV industry’s fastest-growing markets, creating new opportunities for automakers with an international footprint. VinFast’s latest expansion reflects that shift.
DUBAI, UNITED ARAB EMIRATES – Media OutReach Newswire – 5 August 2026 – For much of the past decade, the global electric vehicle conversation has revolved around three markets: China, the United States, and Europe. But recent industry data suggests the next chapter may be written elsewhere.
According to the International Energy Agency (IEA), global car sales fell about 5% in the first half of 2026 as economic pressures, fuel price volatility and policy changes weighed on demand in China and the US. Yet electric vehicle sales rebounded strongly in the second quarter, reaching record levels in 50 countries. Markets including Vietnam, India, Australia and South Korea roughly doubled EV sales compared with a year earlier, while more than 90 countries posted year-on-year growth during the first half of the year.
The shift reflects a broader change in where future industry growth is likely to come from. While China remains the world’s largest EV market, the IEA expects sales there to stagnate this year for the first time this decade, even as electric vehicles account for more than 60% of new car sales. Meanwhile, emerging markets are becoming increasingly important, supported by expanding policy incentives, growing charging infrastructure and rising consumer interest.
The agency also notes that China and other emerging economies are expected to account for around 60% of global car demand over the next decade, making success in these markets an increasingly important determinant of future automotive leadership.
VinFast’s latest performance reflects this changing landscape.
The Vietnamese automaker delivered 70,085 electric vehicles globally in the second quarter of 2026, up 96% year-on-year, bringing first-half deliveries to 128,662 vehicles, a 78% increase from the same period last year. The company’s two-wheel business also continued to expand rapidly, with 286,039 electric scooters and e-bikes delivered during the quarter, up 311% year-on-year.
The delivery mix also highlights the importance of products designed for diverse market needs. Models ranging from the compact VF 3 and VF 5 to the Limo Green MPV and the newly introduced VF MPV 7 all contributed meaningfully to second-quarter volumes, suggesting demand is spread across both personal mobility and commercial transportation segments.
Just as significant is where those vehicles are going.
In July, VinFast exported more than 5,000 electric vehicles aboard two dedicated vessels. One shipment, consisting of approximately 1,500 VF 6 SUVs, was designated for partner Green SM’s planned expansion in Europe, while another transported more than 3,500 vehicles to the Philippines and Indonesia. The voyages marked VinFast’s 37th and 38th international export shipments in fewer than four years, underscoring the increasing operational scale behind its global expansion.
VinFast’s effort in international market, including in the Middle East, shows that as growth becomes more geographically diversified, automakers can no longer rely on a handful of mature markets to drive expansion. Instead, success will increasingly depend on building products, distribution networks and operations that can compete across a wide range of emerging economies.
For the global EV industry, the center of gravity is not disappearing from established markets. It is becoming far more distributed. VinFast’s recent momentum suggests that companies positioned across multiple high-growth regions may be among the best placed to benefit from that shift.
Hashtag: #VinFast
The issuer is solely responsible for the content of this announcement.
Media OutReach
EM Services and SPTel Partner to Advance Smart Estate Management Through Digital Connectivity and IoT Solutions
- Faster detection of estate issues
- Faster response and resolution times
- Better use of manpower and resources
- Better services and living environments for residents
CEO
EM Services
Chief Executive Officer
SPTel
Hashtag: #EMServices #SPTel
The issuer is solely responsible for the content of this announcement.
About EM Services
About SPTel
